- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 13, 2025 | 32.04M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $27.64K |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $10.55M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.79M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $992.59K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $20.36M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $24.96M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $20.84M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $25.51M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $5.01M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $3.48M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $27.82M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $26.65M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 11.96M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $75.57K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$1.41M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $11.24M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $16.14M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.55 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.55 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $3.98M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$6.61M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$4.9M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $706.22K |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $7.32M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $8.03M |